Evaluation of oxidative stress effects on different macromolecules in adult growth hormone deficiency

PLoS One. 2020 Jul 20;15(7):e0236357. doi: 10.1371/journal.pone.0236357. eCollection 2020.

Abstract

Adult growth hormone deficiency (GHD) is being increasingly recognized to cause premature mortality exacerbated by oxidative stress. A case-control observational study has been performed with the primary objective of evaluating new parameters of oxidative stress and macromolecular damage in adult GHD subjects: serum nitrotryptophan; Total Antioxidant Capacity expressed as LAG time; urinary hexanoil-lysine; urinary dityrosine and urinary 8-OH-deoxyguanosine. GHD was diagnosed using Growth Hormone-Releasing Hormone 50μg iv+arginine 0,5 g/Kg test, with a peak GH response <9 μg /L when BMI was <30 kg/m2 or <4 μg/L when BMI was >30 kg/m2. Patients affected by adult GHD were divided into three groups, total GHD (n = 26), partial GHD (n = 25), and controls (n = 29). Total Antioxidant Capacity, metabolic and hormonal parameters have been determined in separate plasma samples; nitrotryptophan in serum samples; hexanoil-lysine, dityrosine, 8-OH-deoxyguanosine in urine samples. Assessment of hexanoil-lysine exhibited a trend to increase in comparing total GHD vs partial and controls, although not significant. Values of 8-OH-deoxyguanosine did not significantly differ among the three groups. Significant lower levels of dityrosine in partial GHD vs total and controls were found. No significant difference in nitrotriptophan serum levels was found, while significantly greater values of Total Antioxidant Capacity were showed in total and partial GHD vs controls. Thus, our result confirm that oxidative stress is increased both in partial and total adult GHD. The lack of compensation by antioxidants in total GHD may be connected to the complications associated to this rare disorder.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2'-Deoxyguanosine / urine
  • Adult
  • Antioxidants / analysis*
  • Arnold-Chiari Malformation / blood
  • Arnold-Chiari Malformation / complications
  • Arnold-Chiari Malformation / metabolism
  • Biomarkers / blood
  • Biomarkers / urine
  • Case-Control Studies
  • Empty Sella Syndrome / blood
  • Empty Sella Syndrome / complications
  • Empty Sella Syndrome / metabolism
  • Female
  • Human Growth Hormone / deficiency*
  • Humans
  • Hypopituitarism / blood
  • Hypopituitarism / etiology
  • Hypopituitarism / metabolism*
  • Hypopituitarism / urine
  • Lipid Peroxidation
  • Lysine / blood
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / metabolism*
  • Metabolic Syndrome / urine
  • Middle Aged
  • Oxidative Stress / physiology*
  • Tryptophan / analogs & derivatives
  • Tryptophan / blood
  • Tyrosine / analogs & derivatives
  • Tyrosine / urine

Substances

  • 4-nitro-tryptophan
  • Antioxidants
  • Biomarkers
  • N(epsilon)-hexanoyllysine
  • Human Growth Hormone
  • Tyrosine
  • 6-nitrotryptophan
  • 8-Hydroxy-2'-Deoxyguanosine
  • Tryptophan
  • dityrosine
  • Lysine

Grants and funding

This study was supported by a non-profit grant (MS200104_0016) released by MerckTM (https://www.merckgroup.com/it-it) to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.